Introduction {#s1}
============

Transcription is a source of genetic instability in eukaryotic cells (reviewed in [@pgen.1002009-Aguilera1]). High transcription rates can result in increased recombination and mutagenesis [@pgen.1002009-Datta1], [@pgen.1002009-Saxe1], and a variety of factors have an influence on this relationship, including the collision between replication forks and the transcription machinery [@pgen.1002009-Mirkin1], and the occurrence of RNA--DNA hybrids (R-loops) [@pgen.1002009-Huertas1], [@pgen.1002009-Yu1]. In mammalian B cells, class switch recombination (CSR) and somatic hypermutation (SHM) are strongly dependent on transcription. Transcription of the switch (S) regions generates DNA intermediates in which the C-rich template strand forms stable R-loops and the non-template G-rich strand can form secondary structures (reviewed in [@pgen.1002009-Chaudhuri1]). Activation Induced Deaminase (AID), an enzyme specifically expressed in mature B cells [@pgen.1002009-Muramatsu1] that is essential in both CSR and SHM, appears to be associated with the transcription machinery [@pgen.1002009-Nambu1]--[@pgen.1002009-Pavri1], and AID-mediated mutations increase when RNAPII is stalled [@pgen.1002009-Canugovi1]. Current models of CSR suggest that AID triggers the process by deaminating cytosines in the non-template DNA strand displaced by the R-loop [@pgen.1002009-Chaudhuri2]--[@pgen.1002009-Yu2]. In addition, during transcription the DNA sequences upstream of the elongating RNA polymerase are negatively supercoiled, and this transient change in DNA topology may allow AID to access both DNA strands [@pgen.1002009-Shen1]. Cytosine residues deaminated by AID at S regions are converted into uracils, which are processed by base excision repair (BER) and/or mismatch repair (MMR) pathways into DSBs responsible for CSR [@pgen.1002009-Rada1]--[@pgen.1002009-DiNoia1]. However, the reason why in B cells uracils lead to DSBs instead of being repaired remains unclear, although a breakdown of the cellular protective error-free repair has been suggested [@pgen.1002009-Liu1]. An open question is whether B cells have specialized functions or DNA modifying enzymes not present in other eukaryotic cells to process uracils into DSBs.

The same mechanism leading to CSR seems to be involved in the formation of chromosomal translocations (CTs) between the immunoglobulin S regions and *c-MYC* (Ig/*myc*) that are associated with B cell-derived Burkitt\'s lymphomas, also mediated by AID [@pgen.1002009-Kuppers1]--[@pgen.1002009-Robbiani1]. CTs are indeed a hallmark of cancer cells [@pgen.1002009-Rabbitts1], [@pgen.1002009-Nussenzweig1], and are mediated by DSBs [@pgen.1002009-Richardson1]. Repair of AID-mediated DSBs occurs via Non-Homologous End Joining (NHEJ) [@pgen.1002009-Lieber1], but in the presence of sequence homology, CTs may also occur by homologous recombination [@pgen.1002009-Elliott1]--[@pgen.1002009-Ruiz1].

R-loops have been shown to accumulate in yeast THO mutants. The THO complex is functionally involved in transcription elongation and mRNP biogenesis [@pgen.1002009-Aguilera2], and depletion of some of its components generates strong transcription impairment and hyper-recombination phenotypes, which are linked to the formation of R-loops [@pgen.1002009-Huertas1]. These phenotypes depend on gene length, GC content and transcription levels [@pgen.1002009-Chavez1], [@pgen.1002009-GarciaRubio1]. Importantly, THO depletion enhances AID-dependent mutations as a consequence of its ability to accumulate R-loops [@pgen.1002009-GomezGonzalez1]. Taking advantage of this ability, we developed a yeast genetic system to study the mechanisms of AID-mediated chromosomal rearrangements. With this system we observed that transcription of S and *c-MYC* sequences in yeast generates AID-mediated DSBs that can be joined with an ectopic HO-induced DSB to yield a reciprocal CT. AID-induced CTs were strongly enhanced in yeast THO null mutants but not in *hpr1-101* mutants, which do not form R-loops, consistent with the idea that AID-mediated DSBs depend on R-loop formation. CTs analyzed took place through NHEJ, confirming that the initial event was a DSB. This study not only provides new clues to understanding the role of mRNP biogenesis in preventing genome rearrangements and the mechanism of AID-mediated genome instability, but it shows that yeast cells, as mammalian B cells, have the factors and pathways required to channel AID-mediated DNA lesions into DSBs responsible for NHEJ-dependent genome rearrangements and CSR.

Results {#s2}
=======

Murine S sequences are hotspots of recombination in yeast THO null mutants overexpressing human AID {#s2a}
---------------------------------------------------------------------------------------------------

We developed different genetic systems to analyze how R-loops initiate genome instability, whether or not via DSBs. As S regions are known to form R-loops in B cells both *in vivo* and *in vitro* [@pgen.1002009-Yu1], [@pgen.1002009-Daniels1]--[@pgen.1002009-Duquette1], which in turn lead to DSBs responsible for CSR, we assayed the ability of these regions to induce recombination between repeats in yeast. We used a direct-repeat recombination assay based on a plasmid with two truncated *GFP* direct repeats sharing 200-bp of homology under control of the *GAL1* promoter [@pgen.1002009-GomezGonzalez1] ([Figure 1](#pgen-1002009-g001){ref-type="fig"}). Different S region fragments, which are characterized by a specific repetitive motif and length, were inserted between the repeats, and recombinants were scored as *GFP+* cells by FACS among total cells. We analyzed sequences derived from murine Sµ and Sγ3 regions, which were 350-bp and 600-bp long, respectively (Sµ350 and Sγ600) [@pgen.1002009-Duquette1], a 1050-bp longer version of Sµ carrying three consecutive repeats of Sµ350 (Sµ1050), and the Sµ350 in reversal orientation (Sµ350*rev*). None of these sequences yielded a significant increase of recombination compared with the control carrying no S sequences in wild-type cells ([Figure 1](#pgen-1002009-g001){ref-type="fig"}).

![AID--induced recombinogenic effect of different murine S sequences in wild-type and THO mutants.\
A diagram of the direct-repeat recombination system is shown on top. GFP-based direct-repeat recombination was detected by FACS in wild-type and *mft1Δ* strains, with or without AID overexpression. Recombination frequencies were obtained as the median value of at least six independent colonies, and are indicated on top of each bar. Median values and the corresponding standard deviations are shown. Statistical analyses were performed with a Mann-Whitney test compared with the control carrying no S sequence cells. \* *p*\<0.001, \*\* *p*\<0.01.](pgen.1002009.g001){#pgen-1002009-g001}

We next tested whether AID had the ability to stimulate recombination at S regions, given its preference to act on ssDNA within R-loops [@pgen.1002009-Chaudhuri2], [@pgen.1002009-Ramiro1]. AID expression did not significantly increase the recombination frequency of the different sequences analyzed in wild-type cells ([Figure 1](#pgen-1002009-g001){ref-type="fig"}). We then analyzed the effect of the *mft1Δ* THO mutation, which induces R-loop formation but do not compromise viability [@pgen.1002009-GarciaRubio1]. Whereas the frequency of *GFP+* recombinants in *mft1Δ* cells not expressing AID was the same as in the wild-type for the different S regions tested, AID overexpression significantly increased it 3-6-fold above wild-type levels ([Figure 1](#pgen-1002009-g001){ref-type="fig"}). These results suggest that the S fragments used here are too short to form R-loops capable of causing detectable hyper-recombination. However, they are able to facilitate the action of AID. As the highest recombination frequency was obtained with the Sµ350 sequence (6.1×10^−3^), with little differences to those of Sµ1050 and Sµ350*rev* ([Figure 1](#pgen-1002009-g001){ref-type="fig"}), we selected Sµ350 for further analyses as the better candidate for the analysis of AID action *in vivo.*

High levels of reciprocal CTs in yeast THO null mutants overexpressing AID {#s2b}
--------------------------------------------------------------------------

In order to unequivocally assay the capacity of R-loops to form DSBs, we developed a yeast system for the detection of reciprocal CTs that should occur via DSBs in the absence of DNA homology. The system is based on two non-homologous halves of the *LEU2* gene (*leu2Δ5′* and *leu2Δ3′*) integrated at chromosomes XV and III, respectively ([Figure 2A](#pgen-1002009-g002){ref-type="fig"}). Upstream to the *leu2Δ5′* at chromosome XV, an HO endonuclease cut site fused to the hygromycin gene and the 246-bp 3′-end of the *ACT1* intron were integrated (*HO-ACT1iΔ5'-leu2Δ5'*). The *leu2Δ3′* sequence, under control of the *GAL1* promoter, followed by the remaining 62-bp of the *ACT1* intron and the Sµ350 sequence (*leu2Δ3′*-*ACT1iΔ3′*-Sµ350) was integrated at the right arm of chromosome III together with the *URA3* gene ([Figure 2A](#pgen-1002009-g002){ref-type="fig"}). As a control we used a similar system carrying no Sµ350 sequence (*leu2Δ3′*-*ACT1iΔ3′*). These genetically engineered chromosomes III and XV were made in haploid MAT**a**-*inc* cells containing the HO endonuclease gene under the *GAL1* promoter, and the endogenous *LEU2* gene and the *ACT1* intron deleted from their chromosomal *loci*. In galactose, the HO endonuclease is activated causing a DSB at the *HO-ACT1iΔ5'-leu2Δ5'* construct on chromosome XV, whereas the *leu2Δ3′*-*ACT1iΔ3′*-Sµ350 on chromosome III is heavily transcribed from the *GAL1* promoter. Therefore, the HO-induced DSBs on chromosome XV could be sealed with a transcription-mediated DSB on chromosome III to lead a Leu+ translocations ([Figure 2A](#pgen-1002009-g002){ref-type="fig"}). These translocations would be expected to contain the breakpoints embedded in a functional *ACT1* intron located between the two *LEU2* gene halves ([Figure 2A](#pgen-1002009-g002){ref-type="fig"}).

![Intron-based assay for chromosomal translocations in yeast.\
(A) Scheme of the translocation system used. There is no sequence homology between the two DNA constructs integrated in chromosomes III and XV. Chromosomal translocations detected generate a galactose-inducible full-length *LEU2* gene harboring a yeast *ACT1* intron sequence inside. Size of chromosomal fragments is indicated. (B) Leu+ translocation frequencies after HO-induced DSBs in both wild-type and *hpr1Δ* cells. The presence (w) or absence (w/o) of the Sµ350 sequence and AID overexpression are indicated. Translocation frequencies were obtained as the median value of at least ten independent colonies for each strain. Median values and the corresponding standard deviations are shown. (C) Molecular karyotype of Leu+ translocants analyzed by PFGE. Agarose gels were stained with ethidium bromide (left) and analyzed by Southern using a radiolabeled *LEU2* probe (right). The electrophoretic mobility of natural yeast chromosomes is indicated. The *LEU2* signal in parental cells corresponds to the two non-homologous halves of *LEU2* integrated in chromosomes III and XV (bold). Chromosomes XV and VII have the same electrophoretic mobility in the experimental conditions used here. The translocated chromosomes containing *LEU2* (tIII/XV) or not containing it (tXV/III), are marked with black triangles, and their sizes are indicated.](pgen.1002009.g002){#pgen-1002009-g002}

After 24h of growth in galactose, Leu+ translocants were obtained at a frequency of 6×10^-9^ in wild-type cells ([Figure 2B](#pgen-1002009-g002){ref-type="fig"}), which indicated that transcription through *leu2Δ3′*-*ACT1iΔ3′*-Sµ350 was indeed able to generate DSBs that were joined to the HO-induced DSB on chromosome XV. This Leu+ frequency was unaffected by overexpression of AID ([Figure 2B](#pgen-1002009-g002){ref-type="fig"}). We then analyzed the effect of a THO null mutation, in this case *hpr1Δ* for its known strong effect in transcription [@pgen.1002009-Chavez2]. Whereas the frequency of translocations in *hpr1Δ* was the same as in wild-type cells not expressing AID (6.1×10^−9^), it increased 19-fold when AID was overexpressed ([Figure 2B](#pgen-1002009-g002){ref-type="fig"}). This effect was specific for the system containing the S sequence (*leu2Δ3′*-*ACT1iΔ3′*-Sµ350), as in the absence of S sequences translocations were not detectable (\<10^−10^; [Figure 2B](#pgen-1002009-g002){ref-type="fig"}). As it has been reported that secondary structures do not form *in vitro* when the sequence is inverted and the G-rich strand is transcribed [@pgen.1002009-Duquette1], we also analyzed the effect of the inverted S sequence (Sµ350*rev*) in our translocation assay, for which we constructed the corresponding *leu2Δ3′*-*ACT1iΔ3′*-Sµ350*rev* on chromosome III. Interestingly, Sµ350*rev* also increased the frequency of translocations in *hpr1Δ* cells overexpressing AID respect to wild-type levels, although it reached lower levels than the forward Sµ350 sequence ([Figure S1](#pgen.1002009.s001){ref-type="supplementary-material"}).

Consistent with previous analyses of direct-repeats recombination ([Figure 1](#pgen-1002009-g001){ref-type="fig"}), the S sequences used here seem to be too short as to form sufficient R-loops to give a significant increase of CTs in wild-type cells with AID or in *hpr1Δ* cells without AID, but they stimulated recombination in *hpr1Δ* cells expressing AID. Altogether, these results indicate that transcription through S regions in yeast can lead to DSBs able to generate CTs. The specific increase caused by AID overexpression in THO mutants suggests that at least a proportion of such DSBs are mediated by R-loops.

AID--mediated translocation breakpoints occur at the S regions {#s2c}
--------------------------------------------------------------

To assess whether Leu+ events corresponded to the expected translocations, chromosomes from twenty independent Leu+ recombinants obtained from *hpr1Δ* yeast overexpressing AID were analyzed by pulsed-field gel electrophoresis (PFGE). Ethidium bromide staining and Southern analysis with a *LEU2* specific probe revealed that all translocated chromosomes showed the pattern expected from the reciprocal joining of the DSBs generated at the S region and HO site in chromosomes III and XV, respectively ([Figure 2C](#pgen-1002009-g002){ref-type="fig"} and [Figure S2](#pgen.1002009.s002){ref-type="supplementary-material"}). This reciprocal translocation resulted in two new chromosomes of 596- and 811-kb long, respectively, with the *LEU2* signal specifically detected in the smaller one, the chromosome in which the two halves of the *LEU2* gene are joined ([Figure 2C](#pgen-1002009-g002){ref-type="fig"} and [Figure S2](#pgen.1002009.s002){ref-type="supplementary-material"}). Concomitantly, parental chromosomes III and XV disappeared. This indicates that translocations in *hpr1Δ* yeast overexpressing AID show a unique and recognizable structure originated by a DSB at the S region.

To map the CT breakpoints we amplified the *ACT1* intron reconstituted within the *LEU2* gene by PCR using specific primers that anneal at the corresponding sequences involved in the translocations on chromosomes III and XV ([Figure 3A](#pgen-1002009-g003){ref-type="fig"}). This amplification generated a variety of DNA fragments longer than the 308-bp of the natural *ACT1* intron ([Figure 3A](#pgen-1002009-g003){ref-type="fig"}), suggesting a non site-specific distribution of the transcription-mediated DSBs along the Sµ350 region. DSBs appeared mainly in the 5′-half of the Sµ350 region, resulting in 13 to 122-nt long S sequence stretches within the reconstituted *ACT1* intron of the translocated chromosomes ([Figure 3B](#pgen-1002009-g003){ref-type="fig"}), which was similar regardless of AID expression ([Figure 3B and 3C](#pgen-1002009-g003){ref-type="fig"}). Analysis of the junctions by sequencing of the PCR products revealed frequent short microhomologies (1-2-nt) between the Sµ and HO breakpoints ([Figure 3C](#pgen-1002009-g003){ref-type="fig"}), and the lost of a few nucleotides (0-3-nt) from the HO cut site in the end-joining process ([Figure 3C](#pgen-1002009-g003){ref-type="fig"}). These data suggest that DSBs are generated by AID deamination at *hpr1Δ-*mediated R-loops in the transcribed Sµ350 regions.

![PCR analysis of CT breakpoints in *hpr1Δ* yeast with the Sµ350 sequence integrated at chromosome III.\
(A) Genomic DNA extracted from Leu+ translocants obtained from *hpr1Δ* yeast with and without AID-overexpression were used to amplify the reconstituted *ACT1* intron by PCR using specific p1 and p2 primers, which anneal at the sequences involved in the translocations on chromosomes III and XV. The PCR reaction yielded fragments with heterogeneous sizes longer than the 308-bp of the full-length *ACT1* intron. (B) Identification of CT breakpoints. PCR products were sequenced to identify the breakpoints at the Sµ350 sequence. Breakpoints from cells with (grey) and without (black) AID-overexpression are indicated by arrows. (C) Sequence analysis of breakpoint junctions. The Sµ350/HO site junctions from six AID- and eight AID+ independent Leu+ translocant strains are shown. The length of the S sequence within the reconstituted *ACT1* intron after the translocation is indicated. Underlined nucleotide residues indicate microhomologies between the Sµ350 and HO cut site sequences. The sequence downstream of the HO cleavage site is shown on top.](pgen.1002009.g003){#pgen-1002009-g003}

AID does not stimulate DSBs in *hpr1-101* mutants not forming R-loops {#s2d}
---------------------------------------------------------------------

Depletion of specific mRNP biogenesis factors, such as THO, generates a transcription elongation impairment that is linked to the accumulation and/or stabilization of R-loops [@pgen.1002009-Huertas1]. Accordingly, we found that transcription of the Sµ350 sequence in *hpr1Δ* yeast reduced the efficiency of the transcription process in our system ([Figure S3](#pgen.1002009.s003){ref-type="supplementary-material"}). In order to determine whether R-loops formed in *hpr1Δ* cells are required for AID-dependent DSBs and CTs, we analyzed CTs in the *hpr1-101* mutant strain, which has been shown not to accumulate stable R-loops during transcription [@pgen.1002009-GomezGonzalez2]. Interestingly, *hpr1-101* cells overexpressing AID showed a strong decrease in CT formation after galactose induction ([Figure 4](#pgen-1002009-g004){ref-type="fig"}), suggesting that the formation of R-loops during transcription of the Sµ region contributes to the generation of the DSBs responsible for CTs in this system.

![Analysis of Leu+ translocations in mutant strains overexpressing AID.\
Details as in [Figure 2B](#pgen-1002009-g002){ref-type="fig"}. Statistical analyses were performed with a Mann-Whitney test compared with *hpr1Δ* cells with the Sµ350 sequence overexpressing AID. \* *p*\<0.001, \*\*\* *p*\<0.05.](pgen.1002009.g004){#pgen-1002009-g004}

AID--induced translocations in yeast THO null mutants are mediated by Ung1 and NHEJ {#s2e}
-----------------------------------------------------------------------------------

The current model proposed for the formation of AID-dependent DSBs suggests that uracils generated after AID-mediated deamination of cytosines are primarily processed by the uracil glycosylase Ung1 leading to abasic sites [@pgen.1002009-DiNoia1]. Subsequent processing of these abasic sites generates the DSBs that are repaired by NHEJ during CSR in mammalian B cells. To assay whether AID-mediated DSBs generated in our yeast system were processed as in B cells, we determined the effect of both *UNG1* and *DNL4* deletions on CT formation. As can be seen in [Figure 4](#pgen-1002009-g004){ref-type="fig"}, both *ung1Δ* and *dnl4Δ* abolished the capacity of AID to induce DSB-mediated translocations in *hpr1Δ* cells. Therefore, as occurs in mammalian B cells, AID-dependent DSBs in yeast are also mediated by Ung1 and repaired by NHEJ. These results validate this yeast chromosomal translocation assay as a model system to study the mechanism by which AID can induce CTs *in vivo.* It reveals that once cytosine deamination is produced, further steps leading to DSBs and rearrangements in B cells may occur by standard and conserved DNA repair functions present from yeast to human cells, and not by B cell specific DNA modifying enzymes.

The *c-MYC* oncogene is a recombination hotspot in yeast THO null mutants {#s2f}
-------------------------------------------------------------------------

The observation that the S regions used in this study become a hotspot for DSBs only in R-loop-forming *hpr1Δ* cells, and by the action of AID, suggests that the sequences used are not long enough to harbor the same structural features as full natural S regions in B cells. In order to test this hypothesis, one possibility was to enlarge the size of the S sequence cloned into our yeast systems. The use of such sequences with high abundance of internal repeats, however, makes them particularly unstable, as deletions between the repeats by single-strand annealing occur at high frequency [@pgen.1002009-Huang1], [@pgen.1002009-Rajagopal1], a problem accentuated in *hpr1Δ* cells. Consequently, we used as an equivalent control the *c-MYC* oncogene. As the S regions of Ig genes, *c-MYC* is characterized by its GC-richness, especially in the 5′ region that includes the first exon and first intron (up to 60% of GC residues). This region forms co-transcriptional secondary structures during transcription *in vitro* [@pgen.1002009-Duquette2], and is frequently hypermutated and involved in reciprocal translocations with the S regions [@pgen.1002009-Ramiro2]. The recent identification of *c-MYC* as a main target of AID-dependent translocations and the demonstration that nuclease-mediated DSBs at *c-MYC* causes similar translocations [@pgen.1002009-Robbiani1] suggest that *c-MYC* carries the same structural features that make S regions highly recombinogenic during transcription in B cells.

Therefore, we cloned a 3.8-kb fragment of the human *c-MYC* gene that included the first exon and the first intron in our *GFP* direct-repeat recombination assay, as a functional and structural equivalent of a long S region. As can be seen in [Figure 5A](#pgen-1002009-g005){ref-type="fig"}, whereas recombination was not affected by the presence of the *MYC* sequence in wild-type cells, regardless of AID expression, a strong increase was seen in *hpr1Δ* cells both without and with AID expression (24-fold and 32-fold increase with respect to the control wild-type, respectively; [Figure 5A](#pgen-1002009-g005){ref-type="fig"}). To test whether these high recombination levels, notably higher than those obtained with the Sµ350 sequence (compare [Figure 1](#pgen-1002009-g001){ref-type="fig"} and [Figure 5A](#pgen-1002009-g005){ref-type="fig"}), were not just due to the presence of a longer DNA sequence between the *GFP* repeats, we tested the effect of the long (4.1 kb) and low GC-rich (40%) sequence of the *LYS2* gene. Recombination levels in this system containing the *LYS2* sequence dropped markedly ([Figure 5A](#pgen-1002009-g005){ref-type="fig"}), indicating that the high recombinogenic behavior of *c-MYC* in this system in *hpr1Δ* was due to both its high GC-content (as compared with *LYS2*) and length (as compared with Sµ350). Therefore, *c-MYC* behaves as a hotspot of recombination in *hpr1Δ* cells that is slightly increased by the action of AID.

![Analysis of recombinogenic potential of the *c-MYC* sequence.\
(A) AID-independent recombinogenic behavior of *c-MYC* in THO mutants. A 3.8-kb fragment of the human *c-MYC*, as well as the control 4.1-kb long *LYS2* sequence, were cloned into the GFP-based direct-repeat recombination system. Details as in [Figure 1](#pgen-1002009-g001){ref-type="fig"}. (B) Leu+ translocation frequencies in *c-MYC*-containing wild-type and *hpr1Δ* cells after HO-induced DSBs. Details as in [Figure 2](#pgen-1002009-g002){ref-type="fig"}. (C) Analysis by PCR of CT breakpoints in *hpr1Δ* yeast at the *c-MYC* sequence. Breakpoints from cells with (grey) and without (black) AID-overexpression are indicated by arrows (top). The analysis of the breakpoint junctions is shown at the bottom. The *c-MYC*/HO cut site junctions from eight AID- and five AID+ independent Leu+ translocant strains are shown. The length of the *c-MYC* sequence within the reconstituted *ACT1* intron in the translocant chromosome is indicated. Underlined nucleotide residues indicate microhomologies between the *MYC* and HO cut site sequences. The sequence downstream of the HO cleavage site is shown on top.](pgen.1002009.g005){#pgen-1002009-g005}

To determine whether the recombinogenic behavior of the *c-MYC* sequence in *hpr1Δ* was due to an accumulation of DSBs, we next tested its effect on the chromosomal translocation assay ([Figure 5B](#pgen-1002009-g005){ref-type="fig"}). For this test, a 2.5-kb *c-MYC* 5′-end fragment, including the first exon and the first intron, was integrated under the inducible *GAL1* promoter at chromosome III, instead of the Sµ350 sequence (*leu2Δ3′*-*ACT1iΔ3′*-*cMYC*). Interestingly, after galactose induction, Leu+ translocants were recovered in wild-type cells more efficiently in the system with *c-MYC* than with Sµ350 (2-fold and 4-fold increase without and with AID expression, respectively; compare [Figure 2B](#pgen-1002009-g002){ref-type="fig"} and [Figure 5B](#pgen-1002009-g005){ref-type="fig"}), suggesting that DSBs are spontaneously induced during transcription of the c-*MYC* sequences, and slightly enhanced by AID. Slightly higher translocation frequencies were obtained in *hpr1Δ* cells (3-fold and 2-fold increase with respect to wild-type cells without or with AID expression, respectively; [Figure 5B](#pgen-1002009-g005){ref-type="fig"}). This translocation frequency, however, was 3-fold lower than that induced by the Sµ350 in *hpr1Δ* cells expressing AID (compare [Figure 2B](#pgen-1002009-g002){ref-type="fig"} and [Figure 5B](#pgen-1002009-g005){ref-type="fig"}). We mapped the translocation breakpoints by PCR and sequencing as previously described. PCR of the breakpoint fragments rendered heterogeneous sizes that were longer than the 308-bp full-length *ACT1* intron (not shown). Breakpoints occurred mainly in the 5′-region of *c-MYC*, resulting in a reconstituted *ACT1* intron slightly longer than that obtained with S sequences (from 38 to 241-nt long; [Figure 5C](#pgen-1002009-g005){ref-type="fig"}). The length of *c-MYC* stretches within the reconstituted *ACT1* intron was the same regardless of whether translocations were obtained with or without AID overexpression ([Figure 5C](#pgen-1002009-g005){ref-type="fig"}). Sequencing of the translocation junctions revealed also frequent microhomologies between the *c-MYC* and the HO cut site ends ([Figure 5C](#pgen-1002009-g005){ref-type="fig"}), which were longer (1-5 nt) than those obtained with Sµ350, regardless of AID expression. The number of nucleotides lost from the HO cut site in the end-joining event was similar to that of Sµ350 ([Figure 5C](#pgen-1002009-g005){ref-type="fig"}).

These data suggest that *c-MYC* behaves as an intrinsic recombination hotspot in yeast THO mutants forming R-loops. Even though AID induce more recombination and DSBs at *c-MYC*, it only causes a slight enhancement of *c-MYC* recombination hotspot activity. This suggests that *c-MYC* can be targeted by recombinogenic DNA breaks in AID-dependent and independent manners in THO mutants, suggesting that a suboptimal mRNP structure is sufficient for *c-MYC* to behave as a fragile site.

Discussion {#s3}
==========

We show here that AID induces DSBs in the immunoglobulin S regions and in the *c-MYC* sequences in yeast THO mutants, which are impaired in mRNP biogenesis. Our data suggest that AID-mediated deamination of cytosines at S sequences in yeast are channeled by the Ung1 activity into DSBs as occurs in mammalian B cells, which are then repaired by NHEJ. The *c-MYC* oncogene, which shares features of S sequences, also acts as a hotspot of recombination in yeast THO mutants. Using a novel translocation assay we show that translocations involving S or *c-MYC* sequences occur efficiently in yeast THO mutants, but poorly in wild-type cells. This study demonstrates that the mechanisms of AID-mediated CSR and AID-dependent translocations are mediated by standard DNA repair functions existing in yeast and human cells. The only requirement for these events to occur is the formation of the appropriate substrates for AID action, as they are the R-loops known to be accumulated in THO null mutants.

It is widely accepted that transcription of S regions plays a primary role in CSR in B cells by generating R-loops that are substrates for efficient AID action [@pgen.1002009-Chaudhuri1]. However, once cytosines at the single-stranded DNA sequence of the R-loop are converted into uracils by AID deamination, it is unclear whether B cells have specific DNA modification enzymes or pathways to channel such uracils into DSBs responsible for CSR or Ig/*myc* translocations instead of being efficiently repaired by either BER or MMR, although a breakdown of the protective accurate repair pathways during the process of B cell maturation has been suggested [@pgen.1002009-Liu1]. Our yeast assay for the detection of translocations generated by the NHEJ-mediated processing of DSBs, reveals that yeast cells also have the capability of processing AID-mediated lesions into DSBs. We found that transcription through mammalian Sµ regions in yeast generates AID-mediated DSBs that can lead to CTs, similarly to B cells. The breakpoints of these translocations are located at the 5\' end of Sµ sequences, where most CSR junctions occur *in vivo* [@pgen.1002009-Shinkura1], and show short nucleotide microhomologies, consistent with data from mammalian B cells [@pgen.1002009-Dunnick1]. Notably, AID-dependent CTs in our assay occur at a low frequency in wild-type cells, but are synergistically enhanced in yeast THO null mutants, which are affected in mRNP biogenesis. This is in agreement with previous results showing the mutagenic and recombinogenic phenotype of yeast overexpressing AID [@pgen.1002009-Poltoratsky1], and that the transcription impairment in yeast THO null mutants enhances AID-dependent mutation of the non-template DNA strand, consistent with its exposure as a single stranded DNA during the transcription elongation in the form of R-loops [@pgen.1002009-GomezGonzalez1]. These results, and the fact that AID-dependent CTs are poorly observed in *hpr1-101* mutants, which do not form R-loops [@pgen.1002009-GomezGonzalez2], suggest that the formation of a suboptimal structure of the ribonucleoparticle around the S region RNA fragment may be a major contributor to the formation and/or stabilization of a R-loop as an optimal substrate for AID action. Therefore, our data open the possibility that mRNP biogenesis may have an impact on the generation of genetic variability in mammalian B cells by controlling the formation of R-loops as an efficient substrate for the action of AID.

It has been reported that CSR is orientation-dependent and that inversion of the S sequences decreases the efficiency of CSR [@pgen.1002009-Tian1], [@pgen.1002009-Shinkura1], as it happens with the formation of sequence-dependent secondary structures in DNA during transcription *in vitro* [@pgen.1002009-Duquette1]. We found in our assays a lesser, although substantial, recombinogenic effect of the Sµ sequence in the reversal orientation, which suggests that in our yeast system the presence of G-rich non-transcribed sequences is not an unique requisite for recombinogenicity. The size of the S region seems important for the recombination hotspot activity in B cells, as longer S regions could generate more extensive R-loops [@pgen.1002009-Zarrin1]. A slight increase of the size of the Sµ sequence in our yeast assay did not enhance the translocation frequency, because it was still below a minimum size. Notably, the long GC-rich c-*MYC* oncogene, used in this study as a structural equivalent of the longer S region, was a hotspot for recombination between direct-repeats and NHEJ-mediated CTs in wild-type yeast in our assays. Genetic instability in *c-MYC* and other oncogenes has been correlated with the GC-richness [@pgen.1002009-Duquette2], [@pgen.1002009-Duquette3], and the identification of c-*MYC* as a target of AID [@pgen.1002009-Robbiani1] also suggests that c-*MYC* shares structural features with S regions that make them highly recombinogenic during transcription in B cells. Interestingly, the recombinogenic potential generated by the transcription of the c-*MYC* sequence in our assays in *hpr1Δ* cells was also observed in the absence of AID expression. This is explained by the direct effect of *hpr1Δ* mutation observed in stability of long and GC-rich sequences such as *c-MYC,* as previously shown for bacterial DNA sequences [@pgen.1002009-Chavez2], and by the lower density of AID-recognition motifs along this sequence. Altogether, our results confirm that *c-MYC* behaves as a natural hotspot of recombination, but this is more pronounced in THO depleted cells. The results suggest that the lower efficiency of mRNP biogenesis caused by THO mutation predispose *c-MYC* to breakage, leading to translocations. The similarity of phenotypes observed for mutations in the THSC/TREX-2 complex [@pgen.1002009-GonzalezAguilera1], which is located at the nuclear periphery in close contact with the nuclear pore complex and also causes transcription and RNA-dependent hyper-recombination, suggests that AID action would enhance DSB formation at S and *c-MYC* sequences provoking NHEJ-mediated translocations also in other mRNP biogenesis mutants, THO mutants being a paradigmatic example.

In summary, our work points to the idea that the structure of the nascent mRNA molecule may be a major determinant in the formation of R-loops at the S regions in B cells *in vivo*. Accordingly, previous data demonstrate that the RNA transcript formed during transcription of S sequences *in vitro* can thread back onto the template DNA strand, leading to an R-loop [@pgen.1002009-Roy1], [@pgen.1002009-Roy2]. Our model yeast system provides a validated assay to study the molecular mechanisms mediated by AID leading to DSBs at S regions and the *c-MYC* oncogene, such as those occurring in B cells responsible for class switching or the Ig/*myc* translocations that are associated with Burkitt\'s lymphomas, thus opening new perspectives in understanding AID-mediated rearrangements.

Materials and Methods {#s4}
=====================

Yeast strains and plasmids {#s4a}
--------------------------

Yeast strains used were isogenic to W303, and are listed in [Table S1](#pgen.1002009.s004){ref-type="supplementary-material"}. GFP direct-repeat system constructs and translocation systems were done as described [@pgen.1002009-Ruiz1], [@pgen.1002009-GomezGonzalez1]. The *hpr1Δ, dnl4Δ* and *ung1Δ* alleles were generated by PCR-based gene replacement and confirmed by PCR and Southern analysis. *hpr1-101* and double mutants (*hpr1Δ dnl4Δ*, *hpr1Δ ung1Δ*) with the translocation system were obtained by genetic crosses.

Determination of recombination frequencies {#s4b}
------------------------------------------

Yeast strains were grown on rich YEPD plates. Recombination tests using the GFP direct-repeat system and translocation assays were done as previously described [@pgen.1002009-Ruiz1], [@pgen.1002009-GomezGonzalez1].

Physical analysis of translocations {#s4c}
-----------------------------------

Translocation analysis was performed by Pulsed Field Gel Electrophoresis (PFGE) and Southern analysis as described [@pgen.1002009-Ruiz1].

Chromosomal breakpoint analysis {#s4d}
-------------------------------

Breakpoint regions were obtained by PCR amplification of genomic DNA extracted from yeast translocants using primers p1 (5′-GTATGTTCTAGCGCTTGC) and p2 (5′-CTAAACATATAATATAGCAACA), purified and sequenced.

Supporting Information {#s5}
======================

###### 

Comparative analysis of Leu+ chromosomal tranlocations in *hpr1Δ* cells overexpressing AID in the presence of Sμ350 or Sμ350 reverse sequences. The control wild-type condition is shown as a reference. Translocation frequencies were obtained as the median value of at least ten independent colonies for each strain and are indicated on top of each bar. Median values and the corresponding standard deviations are shown. Statistical analysis was performed with a Mann-Whitney test compared with *hpr1Δ* cells with the Sμ350 sequence overexpressing AID. \*\*\* *p\<*0.05.

(TIF)

###### 

Click here for additional data file.

###### 

Molecular karyotype of 12 independent Leu+ translocants from *hpr1Δ* cells overexpressing AID analyzed by PFGE and Southern blot. Agarose gel was stained with ethidium bromide (top) and analyzed by Southern using a radiolabeled *LEU2* probe (bottom). The electrophoretic mobility of natural yeast chromosomes is indicated. The translocated chromosomes containing *LEU2* (tIII/XV) or not containing it (tXV/III) are marked with black triangles, and their sizes are indicated.

(TIF)

###### 

Click here for additional data file.

###### 

Transcription of the Sμ sequence in *hpr1Δ* yeast. A diagram of the expected transcriptional products is shown on top. Total RNA was extracted from both wild-type and *hpr1Δ* yeast at intervals after induction of the translocation system with galactose. Same quantity of RNA of each sample was used for Northern analysis. Hybridization was performed with a radiolabeled *LEU2* probe. Methylen-blue staining of the blot showing the ribosomal RNA levels of the samples is shown at the bottom.

(TIF)

###### 

Click here for additional data file.

###### 

Yeast strains used in this study.

(PDF)

###### 

Click here for additional data file.

We thank A. Gabriel, A Bhagwat, and N. Maizels for reagents; B. Pardo and M. Moriel-Carretero for helpful discussions; and D. Haun for style supervision.

The authors have declared that no competing interests exist.

This work was funded by grants from the Spanish Ministry of Science and Innovation (BFU2006-05260 and Consolider Ingenio 2010 CSD2007-015) and Junta de Andalucía (BIO102 and CVI4567). JFR was recipient of a \"Juan de la Cierva\" postdoctoral fellowship from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

[^1]: Conceived and designed the experiments: JFR AA. Performed the experiments: JFR BGG. Analyzed the data: JFR BGG AA. Contributed reagents/materials/analysis tools: JFR BGG AA. Wrote the paper: JFR BGG AA.
